13108 Federal Register / Vol. 72, No. 53 / Tuesday, March 20, 2007 / Notices 

located at 888 First Street, NE, Room 

2A, Washington, DC 20426, or by calling 

(202) 502–8371. This filing may also be 

viewed on the Commission’s Web site at 

http://www.ferc.gov using the 

‘‘eLibrary’’ link. Enter the docket 

number excluding the last three digits in 

the docket number field to access the 

document. You may also register online 

at http://www.ferc.gov/docs-filing/ 

esubscription.asp to be notified via email of new filings and issuances 

related to this or other pending projects. 

For assistance, call 1–866–208–3676 or 

e-mail FERCOnlineSupport@ferc.gov, 

for TTY, call (202) 502–8659. A copy is 

also available for inspection and 

reproduction at the address in item (h) 

above. 

m. Individuals desiring to be included 

on the Commission’s mailing list should 

so indicate by writing to the Secretary 

of the Commission. 

n. Comments, Protests, or Motions to 

Intervene: Anyone may submit 

comments, a protest, or a motion to 

intervene in accordance with the 

requirements of Rules of Practice and 

Procedure, 18 CFR 385.210, 385.211, 

385.214. In determining the appropriate 

action to take, the Commission will 

consider all protests or other comments 

filed, but only those who file a motion 

to intervene in accordance with the 

Commission’s Rules may become a 

party to the proceeding. Any comments, 

protests, or motions to intervene must 

be received on or before the specified 

comment date for the particular 

application. 

o. Filing and Service of Responsive 

Documents: Any filings must bear in all 

capital letters the title ‘‘COMMENTS’’, 

‘‘RECOMMENDATIONS FOR TERMS 

AND CONDITIONS’’, ‘‘PROTEST’’, OR 

‘‘MOTION TO INTERVENE’’, as 

applicable, and the Project Number of 

the particular application to which the 

filing refers. A copy of any motion to 

intervene must also be served upon each 

representative of the Applicant 

specified in the particular application. 

p. Agency Comments: Federal, state, 

and local agencies are invited to file 

comments on the described 

applications. A copy of the applications 

may be obtained by agencies directly 

from the Applicant. If an agency does 

not file comments within the time 

specified for filing comments, it will be 

presumed to have no comments. One 

copy of an agency’s comments must also 

be sent to the Applicant’s 

representatives. 

q. Comments, protests and 

interventions may be filed electronically 

via the Internet in lieu of paper. See, 18 

CFR 385.2001(a)(1)(iii) and the 

instructions on the Commission’s Web 

site at http://www.ferc.gov under the ‘‘eFiling’’ link. 

Philis J. Posey, 

Acting Secretary. 

[FR Doc. E7–5015 Filed 3–19–07; 8:45 am] 

BILLING CODE 6717–01–P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR Part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The applications listed below, as well 

as other related filings required by the 

Board, are available for immediate 

inspection at the Federal Reserve Bank 

indicated. The application also will be 

available for inspection at the offices of 

the Board of Governors. Interested 

persons may express their views in 

writing on the standards enumerated in 

the BHC Act (12 U.S.C. 1842(c)). If the 

proposal also involves the acquisition of 

a nonbanking company, the review also 

includes whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843). Unless otherwise 

noted, nonbanking activities will be 

conducted throughout the United States. 

Additional information on all bank 

holding companies may be obtained 

from the National Information Center 

website at www.ffiec.gov/nic/. 

Unless otherwise noted, comments 

regarding each of these applications 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than April 13, 2007. 

A. Federal Reserve Bank of New 

York (Anne McEwen, Financial 

Specialist) 33 Liberty Street, New York, 

New York 10045-0001: 

1. The Bank of New York Mellon 

Corporation, New York, New York; to 

become a bank holding company by 

acquiring and merging with The Bank of 

New York Company, Inc., New York, 

New York, and thereby indirectly 

acquire The Bank of New York, New 

York, New York; B.N.Y. Holdings 

(Delaware) Corporation, Newark, 

Delaware; The Bank of New York 

(Delaware), Newark, Delaware; Mellon 

Financial Corporation, Pittsburgh, 

Pennsylvania; Mellon Bank, N.A., 

Pittsburgh, Pennsylvania; Mellon 

United National Bank, Miami, Florida; 

Mellon 1st Business Bank, National 

Association, Los Angeles, California; 

and Mellon Trust of New England, N.A., 

Boston, Massachusetts. 

B. Federal Reserve Bank of Chicago 

(Patrick M. Wilder, Assistant Vice 

President) 230 South LaSalle Street, 

Chicago, Illinois 60690-1414: 

1. 1st Source Corporation, South 

Bend, Indiana; to acquire 100 percent of 

the voting shares of FINA Bancorp, Inc., 

Valparaiso, Indiana, and thereby 

indirectly acquire First National Bank of 

Valparaiso, Valparaiso, Indiana. 

C. Federal Reserve Bank of San 

Francisco (Tracy Basinger, Director, 

Regional and Community Bank Group) 

101 Market Street, San Francisco, 

California 94105-1579: 

1. Belvedere SoCal, San Francisco, 

California; to become a bank holding 

company by acquiring 100 percent of 

the voting shares of Professional 

Business Bank, Pasadena, California. In 

connection with this application, 

Belvedere Capital Partners II, LLC, and 

Belvedere Capital Fund II, LP, San 

Francisco, California, will indirectly 

acquire up to 58 percent of the voting 

shares of Professional Business Bank, 

Pasadena, California. 

Board of Governors of the Federal Reserve 

System, March 14, 2007. 

Robert deV. Frierson, 

Deputy Secretary of the Board. 

[FR Doc. E7–4980 Filed 3–19–07; 8:45 am] 

BILLING CODE 6210–01–S 

FEDERAL RESERVE SYSTEM 

Notice of Proposals to Engage in 

Permissible Nonbanking Activities or 

to Acquire Companies that are 

Engaged in Permissible Nonbanking 

Activities 

The companies listed in this notice 

have given notice under section 4 of the 

Bank Holding Company Act (12 U.S.C. 

1843) (BHC Act) and Regulation Y (12 

CFR Part 225) to engage de novo, or to 

acquire or control voting securities or 

assets of a company, including the 

companies listed below, that engages 

either directly or through a subsidiary or 

other company, in a nonbanking activity 

that is listed in § 225.28 of Regulation Y 

(12 CFR 225.28) or that the Board has 

determined by Order to be closely 

related to banking and permissible for 

bank holding companies. Unless 

otherwise noted, these activities will be 

conducted throughout the United States. 


pwalker on PROD1PC71 with NOTICES
Federal Register / Vol. 72, No. 53 / Tuesday, March 20, 2007 / Notices 13109 

1http://www.whitehouse.gov/news /releases/ 

2002/12/WMDStrategy.pdf. 2http://www.whitehouse.gov/homeland/ 

20040430.html. 

3http://www.whitehouse.gov/news/ releases/ 

2007/02/20070207–2.html. 

4Federal Register, Vol. 71, No. 129, Thursday, 

July 6, 2006, Notices. 

5Formerly the Office of Public Health Emergency 

Preparedness; changed to reflect the Pandemic and 

All-Hazards Preparedness Act enacted on December 

19, 2006 (P.L. 109–417). 

Each notice is available for inspection 

at the Federal Reserve Bank indicated. 

The notice also will be available for 

inspection at the offices of the Board of 

Governors. Interested persons may 

express their views in writing on the 

question whether the proposal complies 

with the standards of section 4 of the 

BHC Act. Additional information on all 

bank holding companies may be 

obtained from the National Information 

Center website at www.ffiec.gov/nic/. 

Unless otherwise noted, comments 

regarding the applications must be 

received at the Reserve Bank indicated 

or the offices of the Board of Governors 

not later than April 3, 2007. 

A. Federal Reserve Bank of 

Richmond (A. Linwood Gill, III, Vice 

President) 701 East Byrd Street, 

Richmond, Virginia 23261-4528: 

1. PSB Holding Corp., Preston, 

Maryland; to engage de novo through its 

subsidiary, Community Bank Mortgage 

Corporation, Easton, Maryland, in the 

origination and sale of residential 

mortgage loans to the secondary market, 

pursuant to section 225.28(b)(1) of 

Regulation Y. 

Board of Governors of the Federal Reserve 

System, March 14, 2007. 

Robert deV. Frierson, 

Deputy Secretary of the Board. 

[FR Doc.E7–4981 Filed 3–19–07; 8:45 am] 

BILLING CODE 6210–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Assistant Secretary for 

Preparedness and Response; HHS 

Public Health Emergency Medical 

Countermeasures Enterprise Strategy 

for Chemical, Biological, Radiological 

and Nuclear Threats 

AGENCY: Office of the Assistant 

Secretary for Preparedness and 

Response, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: The United States faces 

serious public health threats from the 

deliberate use of weapons of mass 

destruction (WMD)—chemical, 

biological, radiological, or nuclear 

(CBRN)—by hostile States or terrorists, 

and from naturally emerging infectious 

diseases that have a potential to cause 

illness on a scale that could adversely 

impact national security. Effective 

strategies to prevent, mitigate, and treat 

the consequences of CBRN threats is an 

integral component of our national 

security strategy. To that end, the 

United States must be able to rapidly 

develop, stockpile, and deploy effective 

medical countermeasures to protect the 

American people. This HHS Public 

Health Emergency Medical 

Countermeasures Enterprise Strategy 

(HHS PHEMCE Strategy) establishes the 

goals and objectives that HHS will 

employ to ensure that medical 

countermeasures are available for 

effective use against the highest priority 

CBRN threats facing the Nation. The 

HHS PHEMCE Strategy considers the 

full spectrum of medical 

countermeasures-related activities, 

including research, development, 

acquisition, storage/maintenance, 

deployment, and utilization. The HHS 

PHEMCE Strategy is consistent with the 

President’s Biodefense for the 21st 

Century and aligned with the National 

Strategy for Medical Countermeasures 

against Weapons of Mass Destruction. 

DATES: This notice is effective as of 

March 14, 2007. 

FOR FURTHER INFORMATION CONTACT: Dr. 

Susan Coller, Policy Analyst, Office of 

Public Health Emergency Medical 

Countermeasures, Office of the Assistant 

Secretary for Preparedness and 

Response at 330 Independence Ave., 

SW., Room G640, Washington, DC 

20201 or by phone: 202–260–1200. 

Introduction 

The United States faces serious public 

health threats from the deliberate use of 

chemical, biological, radiological, or 

nuclear (CBRN) weapons of mass 

destruction (WMD) by hostile states or 

terrorists, and from naturally emerging 

infectious diseases that have the 

potential to cause illness on a scale that 

could adversely impact national 

security. The type and magnitude of 

both CBRN and naturally-occurring 

threats are evolving. Chemical 

exposures can result from accidents as 

well as deliberate releases. Advances in 

biotechnology support the development 

of new medical treatments, but also 

make those same tools more widely 

available to adversaries who might use 

them to modify biological organisms 

with the intention to inflict harm. New 

diseases, like Severe Acute Respiratory 

Syndrome (SARS), emerge; and 

regionally endemic diseases, like West 

Nile Fever and Rift Valley Fever, are 

introduced into susceptible populations. 

Nuclear technologies may proliferate 

despite international efforts to contain 

them. 

A failure to anticipate these threats or 

the lack of a capacity to effectively 

prevent them could leave an untold 

number of Americans dead or 

permanently disabled. The United 

States must be able to effectively 

develop, stockpile, and rapidly deploy 

critical medical countermeasures to 

prevent, mitigate, and treat the adverse 

health consequences of threats both 

natural and manmade. Given the diverse 

and dynamic nature of these threats, 

and the expense and time required to 

develop threat agent-specific medical 

countermeasures, a strategy must be 

developed that prioritizes investment 

and optimizes the ability to protect the 

Nation. 

The Role of the Department of Health 

and Human Services in Public Health 

Preparedness 

Within the Federal government, the 

Department of Health and Human 

Services (HHS) leads the research, 

development, acquisition, deployment, 

and use of effective medical 

countermeasures to protect the civilian 

population from WMD. This key role 

was identified in the National Strategy 

to Combat Weapons of Mass 

Destruction,1 Biodefense for the 21st 

Century,2 and the National Strategy for 

Medical Countermeasures against 

Weapons of Mass Destruction,3 which 

together are the President’s blueprint for 

addressing the Nation’s CBRN defense 

programs. 

Within HHS, multiple operating and 

staff divisions work together to develop 

and implement strategies to prevent and 

control disease, injury, illness, and 

disability from terrorist threats and 

naturally-occurring diseases capable of 

negatively impacting Government and 

social systems. In July 2006, HHS 

created the Public Health Emergency 

Medical Countermeasures Enterprise 

(PHEMCE).4 The PHEMCE is a 

coordinated, intra-agency effort led by 

the Office of the Assistant Secretary for 

Preparedness and Response 5 (ASPR) 

and includes three HHS internal 

agencies: the Centers for Disease Control 

and Prevention (CDC), the Food and 

Drug Administration (FDA), and the 

National Institutes of Health (NIH). The 

mission of the PHEMCE is to: (1) Define 

and prioritize requirements for public 

health emergency medical 

countermeasures; (2) integrate and 

coordinate research, early and late stage 

product development, and procurement 

activities addressing the requirements; 

and (3) set deployment and use 


pwalker on PROD1PC71 with NOTICES